|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-6-28
|
|
pubmed:abstractText |
Optimal first-step antihypertensive drug therapy in type 2 diabetes mellitus (DM) or impaired fasting glucose levels (IFG) is uncertain. We wished to determine whether treatment with a calcium channel blocker or an angiotensin-converting enzyme inhibitor decreases clinical complications compared with treatment with a thiazide-type diuretic in DM, IFG, and normoglycemia (NG).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0003-9926
|
|
pubmed:author |
pubmed-author:ALLHAT Collaborative Research Group,
pubmed-author:BarzilayJoshuaJ,
pubmed-author:CushmanWilliam CWC,
pubmed-author:DavisBarry RBR,
pubmed-author:IiamathiEkambaramE,
pubmed-author:KostisJohn BJB,
pubmed-author:LeenenFrans H HFH,
pubmed-author:LouisGail TGT,
pubmed-author:MargolisKaren LKL,
pubmed-author:MathisDavid EDE,
pubmed-author:MolooJamalJ,
pubmed-author:NwachukuChukeC,
pubmed-author:PanebiancoDeborahD,
pubmed-author:ParishDavid CDC,
pubmed-author:PresselSaraS,
pubmed-author:SimmonsDebra LDL,
pubmed-author:ThadaniUdhoU,
pubmed-author:WheltonPaul KPK
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
165
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1401-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15983290-Aged,
pubmed-meshheading:15983290-Amlodipine,
pubmed-meshheading:15983290-Antihypertensive Agents,
pubmed-meshheading:15983290-Blood Glucose,
pubmed-meshheading:15983290-Chlorthalidone,
pubmed-meshheading:15983290-Coronary Disease,
pubmed-meshheading:15983290-Diabetes Mellitus, Type 2,
pubmed-meshheading:15983290-Double-Blind Method,
pubmed-meshheading:15983290-Female,
pubmed-meshheading:15983290-Follow-Up Studies,
pubmed-meshheading:15983290-Humans,
pubmed-meshheading:15983290-Hypoglycemia,
pubmed-meshheading:15983290-Lisinopril,
pubmed-meshheading:15983290-Male,
pubmed-meshheading:15983290-Middle Aged,
pubmed-meshheading:15983290-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
|
pubmed:affiliation |
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA. pwhelton@tulane.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
